The WTSI has a strong program in medical sequencing and has developed a very efficient, accurate high-throughput pipeline for genomic re-sequencing as a result, said Dr. Dan Turner, head of Sequencing Technology Development, WTSI. It therefore needs a system that is robust, reproducible, easy to use and easily scalable to cope with the anticipated large numbers of exomes we hope to sequence in the near future.

SureSelect Human All Exon kits will be available for both the Illumina GA II and Life Technologies SOLiD System, with the initial product offered for paired-end sequencing on the system from Illumina. The product optimized for SOLiD will follow shortly and is in the final stages of optimization.

Agilent ™s SureSelect Target Enrichment System is now the platform with the most optimized protocols for a diverse set of sequencing protocols and platforms. It supports Illumina end-sequencing and paired-end sequencing protocols in addition to fragment library format sequencing on the SOLiD System. This technology enables users of Agilent ™s eArray on-line design tool to improve the efficiency of their research by allowing them to efficiently design custom products to target 5-6 Mb of any genome of interest, all in a single tube.

Source: Agilent Technologies Inc.